Cannabics Pharma Stock Forecast

Evaluation of Cannabics Pharma stock downgraded after the last trading session.
(Updated on Apr 24, 2024)

CNBX Signals & Forecast

A buy signal was issued from a pivot bottom point on Thursday, April 18, 2024, and so far it has risen 15.14%. Further rise is indicated until a new top pivot has been found. Furthermore, there is a buy signal from the 3 month Moving Average Convergence Divergence (MACD). Some negative signals were issued as well, and these may have some influence on the near short-term development. The Cannabics Pharma stock holds a buy signal from the short-term Moving Average; at the same time, however, the long-term average holds a general sell signal. Since the longterm average is above the short-term average there is a general sell signal in the stock giving a more negative forecast for the stock. On further gains, the stock will meet resistance from the long-term Moving Average at $0.0136. On a fall, the stock will find some support from the short-term average at $0.0118. A break-up through the long-term average will give another buy signal, while a fall below the short-term average will add another sell signal and strengthen the general signal. Cannabics Pharma gained volume on the last day, but on falling prices. In technical terms, this is called divergence and may be an early warning. In some cases, increasing volume on falling prices may be considered positive, but that is mainly in typical "sell-offs". The very low volume increases the risk and reduces the other technical signals issued.

Support, Risk & Stop-loss for Cannabics Pharma stock

On the downside, the stock finds support just below today's level from accumulated volume at $0.0112 and $0.0110. There is a natural risk involved when a stock is testing a support level, since if this is broken, the stock then may fall to the next support level. In this case, Cannabics Pharma finds support just below today's level at $0.0112. If this is broken, then the next support from accumulated volume will be at $0.0110 and $0.0106.

This stock may move very much during the day (volatility) and with a very large prediction interval from the Bollinger Band this stock is considered to be "very high risk". During the last day, the stock moved $0 between high and low, or 0%. For the last week, the stock has had daily average volatility of 9.61%.

Our recommended stop-loss: We hold a negative evaluation for this stock. No stop-loss is set.

Trading Expectations (CNBX) For The Upcoming Trading Day Of Thursday 25th

For the upcoming trading day on Thursday, 25th we expect Cannabics Pharma to open at $0.0120, and during the day (based on 14 day Average True Range), to move between $0.0094 and $0.0146, which gives a possible trading interval of +/-$0.0026 (+/-21.62%) up or down from last closing price. If Cannabics Pharma takes out the full calculated possible swing range there will be an estimated 43.25% move between the lowest and the highest trading price during the day.

Since the stock is closer to the resistance from accumulated volume at $0.0125 (4.38%) than the support at $0.0112 (6.89%), our systems don't find the trading risk/reward intra-day attractive and any bets should be held until the stock is closer to the support level.

Is Cannabics Pharma stock A Buy?

Cannabics Pharma holds several negative signals and we believe that it will still perform weakly in the next couple of days or weeks. We, therefore, hold a negative evaluation of this stock. Due to some small weaknesses in the technical picture we have downgraded our analysis conclusion for this stock since the last evaluation from a Hold/Accumulate to a Sell candidate.

Current score: -1.507 Sell Candidate Downgraded

Predicted Opening Price for Cannabics Pharma of Thursday, April 25, 2024

The predicted opening price is based on yesterday's movements between high, low, and closing price.